TREATMENTS &
RESEARCH

Search the
latest
treatment
information
here.

Dr. Huntley's
Diagnosis
Checklist

Have a symptom?
See what questions
a doctor would ask.

Diseases » Papilloma » Clinical Trials

Clinical Trials for Papilloma

Clinical trials are research studies conducted in an effort to improve overall patient health and care. Each trial involves running supervised tests to determine the effectiveness and safety of new drugs, procedures and/or devices with the aim of answering scientific questions about a disease or condition. Risks and side-effects are also evaluated during these trials with results ranging from being unpleasant, with side effects such as headaches, to more serious or even life-threatening risks. A clinical trial may be separated into phases, or steps, with each step designed to answer a separate research question. This maybe reflected in the trial name.

A brief description of each phase:

Phase I: Usually designed to evaluate safety, determine a safe dosage range, and identify side effects on a small group of patients.
Phase II: If Phase I is successful, the trial is then repeated with a larger group to further evaluate its effect and safety.
Phase III: Trials are conducted on an ever larger group and are compared with the best current treatment while gathering more information on effect and safety.
Phase IV: These studies monitor long-term side effects after the treatment has been marketed.

Clinical Trials data for Papilloma is grouped into the following categories:-

View by trial name

View by drugs used in Papilloma clinical trials

Clinical Trials by trial name

The format for each of the following is:

The name of the trial,
followed by whether the trial is recruiting patients,
- The trial may not have started and not yet recruiting, or the trial may have started and do not need any more recruitements, or the trial may be completed.
- Note**: Please follow the link to determine the current trial status.
followed by a list of drug/s, if any, used in the trial

ClinicalTrials.gov has listed the following trials for Papilloma:

The Effects of Upper Airway and Digestive Tract Tumors on the Immune System - This study has been completed (Current: 23 Nov 2006)
A Trial Study of SGN-00101 in Treating Pediatric Patients With Recurrent Respiratory Papillomatosis - This study is currently recruiting patients (Current: 23 Nov 2006) - SGN-00101
Papilloma Virus Vaccine Therapy in Treating Young Patients With Recurrent Papilloma of the Larynx - This study is no longer recruiting patients (Current: 23 Nov 2006) - autologous tumor cell vaccine
Treatment With Cidofovir for Children With Laryngeal Papillomatosis (Warts in the Throat) - This study has been completed (Current: 23 Nov 2006) - Cidofovir
The Effects of Combination Anti-HIV Medication on Human Papillomavirus (HPV) in HIV-Infected Women - This study is no longer recruiting patients (Current: 23 Nov 2006)
Human Papilloma Virus DNA Self-Test - This study is no longer recruiting patients (Current: 23 Nov 2006)
Penclomedine in Treating Patients With Solid Tumors or Lymphoma - This study has been completed (Current: 23 Nov 2006) - penclomedine
Fluconazole in Preventing Mucositis in Patients Undergoing Radiation Therapy for Head and Neck Cancer - This study has been completed (Current: 23 Nov 2006) - infection prophylaxis/management,fluconazole
Megestrol to Limit Weight Loss and Improve Quality of Life in Treating Patients With Head and Neck Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006) - nutritional support,megestrol
Cevimeline in Treating Patients With Dry Mouth Caused by Radiation Therapy for Head and Neck Cancer - This study is currently recruiting patients (Current: 23 Nov 2006) - cevimeline
Zinc Sulfate in Preventing Loss of Sense of Taste in Patients Undergoing Radiation Therapy for Head and Neck Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006) - zinc sulfate
Acupuncture or Standard Therapy in Treating Pain and Dysfunction in Patients Who Have Undergone Neck Surgery for Head and Neck Cancer - This study is currently recruiting patients (Current: 23 Nov 2006)
GM-CSF Mouthwash for Preventing and Treating Mucositis in Patients Who Are Undergoing Radiation Therapy for Head and Neck Cancer - This study is currently recruiting patients (Current: 23 Nov 2006) - sargramostim
Ecteinascidin 743 in Treating Adults With Advanced Solid Tumors - This study is no longer recruiting patients (Current: 23 Nov 2006) - ecteinascidin 743
Combination Chemotherapy in Treating Patients With Advanced Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006) - fluorouracil,leucovorin calcium,topotecan
Interleukin-12 Followed by Interferon Alfa in Treating Patients With Advanced Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006) - interferon alfa,interleukin-12
Combination Chemotherapy Plus Amifostine in Treating Patients With Advanced Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006) - amifostine,carboplatin,cyclophosphamide,sargramostim
Docetaxel in Treating Patients With Solid Tumors and Abnormal Liver Function - This study is no longer recruiting patients (Current: 23 Nov 2006) - docetaxel
Chemotherapy in Treating Patients With Solid Tumors - This study is no longer recruiting patients (Current: 23 Nov 2006) - augmerosen,docetaxel
Combination Chemotherapy Plus Amifostine in Treating Patients With Metastatic or Unresectable Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006) - amifostine,carboplatin,etoposide,filgrastim,ifosfamide
Liposomal Lurtotecan Plus Cisplatin in Treating Patients With Advanced or Metastatic Solid Tumors - This study is no longer recruiting patients (Current: 23 Nov 2006) - cisplatin,lurtotecan liposome
Decitabine in Treating Patients With Melanoma or Other Advanced Cancer - This study has been completed (Current: 23 Nov 2006) - decitabine
Combination Chemotherapy in Treating Patients With Metastatic Solid Tumors - This study has been completed (Current: 23 Nov 2006) - irinotecan,LY231514
Combination Chemotherapy in Treating Patients With Advanced Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006) - fluorouracil,leucovorin calcium,SCH 66336
Physician-Initiated Stop-Smoking Program for Patients Receiving Treatment for Early-Stage Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006) - nicotine
Docetaxel in Treating Patients With Solid Tumors - This study is no longer recruiting patients (Current: 23 Nov 2006) - docetaxel
Chemotherapy in Treating Patients With Refractory Advanced Solid Tumors or Hematologic Cancer - This study has been completed (Current: 23 Nov 2006) - 17-N-allylamino-17-demethoxygeldanamycin
Capecitabine Combined With Cisplatin in Treating Patients With Locally Advanced or Metastatic Solid Tumors - This study is no longer recruiting patients (Current: 23 Nov 2006) - capecitabine,cisplatin
Vaccine Therapy in Treating Patients With Advanced or Recurrent Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006) - human papillomavirus 16 E6 peptide,human papillomavirus 16 E7 peptide
MS-275 in Treating Patients With Advanced Solid Tumors or Lymphoma - This study is no longer recruiting patients (Current: 23 Nov 2006) - MS-275
Bevacizumab, Fluorouracil, and Hydroxyurea Plus Radiation Therapy in Treating Patients With Advanced Head and Neck Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006) - bevacizumab,filgrastim,fluorouracil,hydroxyurea
Docetaxel and St. John's Wort in Treating Patients With Solid Tumors That Cannot Be Removed By Surgery - This study has been suspended (Current: 23 Nov 2006) - Hypericum perforatum,docetaxel
Suberoylanilide Hydroxamic Acid in Treating Patients With Advanced Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006) - suberoylanilide hydroxamic acid
17-DMAG in Treating Patients With Metastatic or Unresectable Solid Tumors - This study is currently recruiting patients (Current: 23 Nov 2006) - 17-dimethylaminoethylamino-17-demethoxygeldanamycin
Erlotinib and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic or Unresectable Kidney, Colorectal, Head and Neck, Pancreatic, or Non-Small Cell Lung Cancer - This study is currently recruiting patients (Current: 23 Nov 2006) - bevacizumab,cetuximab,erlotinib hydrochloride
Erlotinib and Cetuximab in Treating Patients With Refractory Advanced or Metastatic Gastrointestinal Cancer, Head and Neck Cancer, Non-Small Cell Lung Cancer, or Colorectal Cancer - This study is not yet open for patient recruitment (Current: 23 Nov 2006) - cetuximab,erlotinib hydrochloride
L-778,123 in Treating Patients With Recurrent or Refractory Solid Tumors - This study is no longer recruiting patients (Current: 23 Nov 2006) - L-778,123
Paclitaxel Plus L-778,123 in Treating Patients With Recurrent or Refractory Solid Tumors or Lymphomas - This study is no longer recruiting patients (Current: 23 Nov 2006) - L-778,123,L-778,123/paclitaxel,paclitaxel
Paclitaxel and Cisplatin Plus Radiation Therapy Followed by Filgrastim in Treating Patients With Recurrent Head and Neck Cancer or Lung Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006) - cisplatin,filgrastim,paclitaxel
Antineoplaston Therapy in Treating Patients With Advanced Head and Neck Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006) - antineoplaston A10,antineoplaston AS2-1
Combination Chemotherapy Plus Filgrastim in Treating Patients With Advanced Solid Tumors - This study is no longer recruiting patients (Current: 23 Nov 2006) - docetaxel,filgrastim,gemcitabine
Vaccine Therapy Plus Biological Therapy in Treating Adults With Metastatic Solid Tumors - This study is no longer recruiting patients (Current: 23 Nov 2006) - DetoxPC,interleukin-2,ras peptide cancer vaccine,sargramostim
Epirubicin, Carboplatin, and Capecitabine in Treating Patients With Unresectable Locally Advanced, Metastatic, or Recurrent Solid Tumor - This study is no longer recruiting patients (Current: 23 Nov 2006) - capecitabine,carboplatin,epirubicin
Photodynamic Therapy in Treating Patients With Skin Cancer or Solid Tumors Metastatic to the Skin - This study is no longer recruiting patients (Current: 23 Nov 2006) - silicon phthalocyanine 4
Erlotinib in Treating Patients With Solid Tumors and Liver or Kidney Dysfunction - This study is no longer recruiting patients (Current: 23 Nov 2006) - erlotinib
UCN-01 and Irinotecan in Treating Patients With Metastatic or Unresectable Solid Tumors - This study has been suspended (Current: 23 Nov 2006) - UCN-01,irinotecan hydrochloride
Thalidomide and Docetaxel in Treating Patients With Advanced Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006) - docetaxel,thalidomide
Gefitinib in Treating Patients With Metastatic or Unresectable Head and Neck Cancer or Non-Small Cell Lung Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006) - gefitinib
NGR-TNF in Treating Patients With Advanced Solid Tumors - This study is currently recruiting patients (Current: 23 Nov 2006) - CNGRC peptide-TNF alpha conjugate
Human Papilloma Virus (HPV) Vaccine Efficacy Trial Against Cervical Pre-Cancer in Young Adults With GSK Biologicals HPV-16/18 - This study is no longer recruiting patients (Current: 23 Nov 2006)
Immediate Treatment Vs Colposcopic Follow-Up for Biopsy-Proven CIN 1 - This study is currently recruiting patients (Current: 23 Nov 2006)
Human Papillomavirus (HPV) Registration Study (Gardasil) - This study is no longer recruiting patients (Current: 23 Nov 2006)
A Study of Amolimogene (ZYC101a) in Patients With High Grade Cervical Intraepithelial Lesions of the Uterine Cervix - This study is currently recruiting patients (Current: 23 Nov 2006) - ZYC101a
Safety and Efficacy Trial of the Use of A-007 Topical Gel in the Treatment of High-Grade Squamous Intraepithelial Lesions (HSIL) of the Cervix - This study is currently recruiting patients (Current: 23 Nov 2006) - A-007
SU5416 and Paclitaxel in Treating Patients With Recurrent, Locally Advanced or Metastatic Cancer of the Head and Neck - This study has been completed (Current: 23 Nov 2006) - SU5416,paclitaxel

Drugs used in Clinical Trials for Papilloma

The format for each of the following is:

The drug,
followed by the name of the trial,
followed by whether the trial is recruiting patients,
- The trial may not have started and not yet recruiting, or the trial may have started and do not need any more recruitements, or the trial may be completed.
- Note**: Please follow the link to determine the current trial status.

ClinicalTrials.gov has listed the following drugs in trials for Papilloma: